Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness and Safety of SMART BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity in Real-life Setting.

NCT05224349 is registered in ClinicalTrials.gov with Ipsen as lead sponsor.

NCT NCT05224349
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05224349 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness and Safety of SMART BoNT-A Therapy With Dysport® in Patients With Post-stroke Chronic Upper Limb Spasticity in Real-life Setting.
Lead sponsor
Ipsen
Phase
Observational
Overall status
Completed
Start date
May 9, 2022
Completion date
July 4, 2025
Enrollment
121 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

post-stroke chronic upper limb spasticity